Stocktoria
Akso Health Group AHG
Akso Health Group (AHG) earns a Piotroski F-score of 3/9 (weak financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 1.70% (safety: no dividend). FY2025 revenue was $13.8M at a -135.0% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.848 |
| Retained earnings / assets | -0.925 |
| EBIT / assets | -0.774 |
| Equity / liabilities | 12.603 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| AHG | Akso Health Group | 3/9 | 10.58 | — | -6.4% |
| RYDE | Ryde Group Ltd | 2/9 | 3.93 | — | — |
| MOGU | MOGU Inc. | — | — | — | -6.6% |
| OLB | OLB GROUP, INC. | 1/9 | — | — | -32.4% |
| WAI | Top KingWin Ltd | 3/9 | 8.42 | — | — |
| CJMB | CALLAN JMB INC. | 1/9 | -11.4 | — | — |
| ASFH | ASIAFIN HOLDINGS CORP. | 4/9 | -1.75 | — | — |
About Akso Health Group
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as technological promotion services and import and export. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.
FAQ
Is AHG financially healthy?
Akso Health Group's Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does AHG pay a dividend, and is it safe?
Yes. Akso Health Group pays a dividend yielding about 1.70% with a None payout ratio, rated “no dividend” for safety.
How profitable is AHG?
In FY2025, Akso Health Group had a net margin of -135.0% and a return on equity of -10.3%.
Is AHG overvalued or undervalued?
Akso Health Group trades at about 146.9× trailing earnings — above its 10-year norm (10-year range 8.5×–219.0×, median 25.1×). Stocktoria reports the data, not buy/sell advice.
Is AHG a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Akso Health Group: a Piotroski F-score of 3/9, an Altman Z″ in the safe zone, a dividend yield of 1.70%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-03-31. Facts plus Stocktoria's own computed scores — not investment advice.